Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CURE vs VT✓SelectedUSD · VTCURE vs VT performance historyLatest closeAs of+1.94%11/13
Stock and ETF performance explorer

CURE vs VT

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+557.9%
VT return
+221.8%
Excess return
+336.1%
Maximum drawdown
-69.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioVTExcessAlpha
1D+1.9%-0.3%+2.2%+2.5%
7D+6.8%+2.4%+4.4%+1.7%
30D+25.9%-1.5%+27.4%+30.1%
3M+35.9%-4.1%+40.0%+48.0%
6M+98.0%+0.6%+97.4%+89.7%
YTD+60.5%+11.0%+49.5%+23.3%
1Y+65.7%+13.3%+52.4%+21.7%
3Y+122.0%+73.4%+48.6%-37.4%
5Y+52.1%+57.4%-5.4%-43.5%
All+557.9%+221.8%+336.1%-33.5%

Cumulative growth

Daily Returns

Daily percentage return beside VT.

Daily Out/Under-Performance

Portfolio return minus VT return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × VT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded VT wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling